Atopic Dermatitis

Emerging

0
Citations
0
Refs
2024
Year
Search Works
Work Details
External Links
OpenAlex Record DOI Resolver PubMed PDF Publisher Page
MENU
0

Atopic Dermatitis

Article 2024 EN Bronze

Aim: Atopic dermatitis (AD) affects 2-7% of adults globally, with 30% experiencing moderate-to-severe disease.Although several treatments for moderate-to-severe AD are available, the efficacy of many treatments has not been compared in head-to-head trials.Using a network meta-analysis (NMA), we evaluated the relative efficacy between lebrikizumab, an emerging biologic and approved targeted systemi…

0

Citations

0

References

5

Authors

0.00

FWCI

Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
5 authors
#AuthorInstitutionsORCID
1 Atopic dermatitis affects – of adults globally — —
2 with experiencing moderate-to-severe disease. Although several treatments for moderate-to-severe AD are available — —
3 the efficacy of many treatments has not been compared in head-to-head trials. Using a network meta-analysis — —
4 we evaluated the relative efficacy between lebrikizumab — —
5 an emerging biologic and approved targeted systemic treatments for AD. — —
Related Works
10

Data: OpenAlex